MedPath

Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis

Phase 4
Recruiting
Conditions
Bronchiolitis
Interventions
Other: Control
Drug: Lavender essential oil 10%, diluted in 90% olive oil
Registration Number
NCT06108648
Lead Sponsor
University Hospital, Geneva
Brief Summary

The goal of this clinical trial is to learn if lavender essential oil chest wraps relieve cough in infants with bronchiolitis compared to standard care. Furthermore, the researchers will evaluate if breathing difficulties, nighttime awakening and impact on parents will be improved by the lavender oil chest wraps. Infants will be randomized to receive standard care with the addition of lavender oil chest wraps or to receive standard care alone. The study will take place in two locations in Switzerland, at the Geneva University Hospital and the Fribourg Cantonal Hospital.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControlStandard care: supportive measures according to national standards.
Lavender oilLavender essential oil 10%, diluted in 90% olive oilLavender chest wrap: Before the first application pour 10-15 ml of lavender essential oil 10% evenly on the cotton cloth. Put the soaked cotton in the plastic bag, close it and put it to heat in two heating pads (2-5 minutes) so that the oil is distributed on all the fabric. Place the cotton cloth around the patient's chest. Cover the cotton cloth with a woolen fabric that is 2 cm larger than the cotton cloth.
Primary Outcome Measures
NameTimeMethod
Cough frequencyUp to 2 days

Number of coughs per hour measured with Hyfe CoughMonitor (Hyfe Inc)

Secondary Outcome Measures
NameTimeMethod
Oxygen supplementation durationImmediately at discharge from hospital

Number of hours of oxygen supplementation

Crying episodesUp to 2 days

Number of crying episodes noted by parents on crying calendar

Hospital length of stayImmediately at discharge from hospital

Hospital length of stay in number of days, Geneva site only

Oxygen supplementation requirementImmediately at discharge from hospital

Presence of oxygen supplementation during hospital stay (yes/no)

Parental satisfaction assessed with patient satisfaction questionnaireImmediately at discharge from hospital

Satisfaction of parents will be measured by a 10-item, four-point Likert scale questionnaire that has a 3-dimensional structure, i.e. overall satisfaction; perceived effectiveness; parental information and involvement. Scale range from 1 (not at all) to 4 (a lot). Higher scores indicate greater satisfaction.

Respiratory rateBaseline, 1 hour, 4 hours

Number of breaths per minute

Maximum oxygen supplementationImmediately at discharge from hospital

Maximum oxygen flow in L/min

Impact on parents assessed by the "Impact of Bronchiolitis Hospitalization Questionnaire" (IBHQ)Immediately at discharge from hospital

Impact from the hospitalization on parents will be measured using IBHQ, a 46-item, four-point Likert scale that has a 12-dimensional structure, i.e. worries and distress; fear for future; guilt; impact on daily organization; physical impact; impact on behaviour with hospitalized child; financial impact; disturbed breastfeeding; physical reaction of hospitalized child; impact on feeding of hospitalized child; impact on behaviour with other children; sibling's reaction. Scale ranges from 1 (not at all) to 4 (a lot). Higher scores indicate higher impact on parents.

Trial Locations

Locations (2)

Clinique de pediatrie, HFR Fribourg - Hopital cantonal, Switzerland

🇨🇭

Fribourg, Switzerland

Children's' Hospital, University Hospital of Geneva, Switzerland

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath